Alexandria Real Estate Equities (ARE) closed at $48.87 on Aug 4, 2026, down 7.8% on the day. The stock is down 2.0% over the past month, up 20.3% over three months, up 2.8% year to date and down 31.8% over the past year. It trades 26.9% below its 52-week high of $66.82 and 25.6% above its 52-week low of $38.90. The close sits below its 50-day moving average ($50.67) and below its 200-day moving average ($50.26).
ARE is scheduled to report earnings on Oct 26, 2026, after market close.
ARE options were pricing 50% at-the-money implied volatility on Oct 21, 2026, an IV rank of 87 over the past year.
Alexandria Real Estate Equities is scheduled to report on Oct 26, 2026, after market close.
No — the Aug 4, 2026 close of $48.87 is 2.8% below the 200-day average of $50.26.
ARE closed 26.9% below its 52-week high of $66.82.
Alexandria Real Estate Equities, Inc., an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. With our founding in 1994, Alexandria pioneered the life science real estate niche. Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative Megacampus ecosystems in AAA life science and advanced technology innovation cluster locations, including Greater Boston, San Diego, the San Francisco Bay Area, Seattle, Maryland, Research Triangle, and New York City. Alexandria Real Estate Equities, Inc. was established in 1994 and was incorporated in Maryland.
